Specialty: Sickle Cell and Hematology

Clinical Interest/Expertise: Sickle Cell and Hematology

Research Interest: Sickle Cell and Hematology

Medical School: Tufts University School of Medicine

Residency:

• Children’s Hospital in Boston, Massachusetts at Harvard University School of Medicine
• Fellowship in Hematology/Oncology at The Dana Farber Cancer Institute in Boston, Massachusetts
• Clinical Research Fellowship at Children’s Hospital of Boston

Board Certification: General Pediatrics and Hematology/Oncology

Other Degrees: Bachelor of Art, University of California, Berkeley

Publications:

• Asare K, Gee BE, Stiles JK, et al. Plasma interleukin-1β concentration is associated with stroke in sickle cell disease. Cytokine 2009; doi:10.1016/j.cyto.2009.10.002 Accepted for publication May 2009.
• Driss A, Asare KO, Hibbert JM, Gee BE, et al. Sickle cell disease in the post genomic era: a monogenic disease with a polygenic phenotype. Genomics Insights on-line publication 2009; 2: 23-48 (accepted June 2009)
• Gee, BE, et al. “Dominant role of SDF-1in the vasculo-angiogenic phenotype of sickle cell disease.” NIH Workshop on Vasculopathy in Sickle Cell Disease, Bethesda, MD, August 2008 (poster presentation)
• Travel award: NIH Workshop on Vasculopathy in Sickle Cell Disease, Bethesda, MD, August 2008
• Gee, BE, et al. “Dominant role of SDF-1 in the vasculo-angiogenic phenotype of sickle cell disease.” American Society of Hematology, San Francisco, CA, December 2008 (poster presentation).